From 60c90017779c5b4fb531690e4020642f4638fd69 Mon Sep 17 00:00:00 2001
From: Marta Girona Alarcon <marta.gironaalarcon@uzh.ch>
Date: Thu, 3 Oct 2024 13:16:43 +0200
Subject: [PATCH] update

---
 .../20240901_Marta_GironaAlarcon/Publication_page.qmd           | 2 +-
 1 file changed, 1 insertion(+), 1 deletion(-)

diff --git a/webpage_contents/publications/20240901_Marta_GironaAlarcon/Publication_page.qmd b/webpage_contents/publications/20240901_Marta_GironaAlarcon/Publication_page.qmd
index da4bd7a..6bc4a6f 100644
--- a/webpage_contents/publications/20240901_Marta_GironaAlarcon/Publication_page.qmd
+++ b/webpage_contents/publications/20240901_Marta_GironaAlarcon/Publication_page.qmd
@@ -57,7 +57,7 @@ In the publication, we have shown the need of infusing contrast agent to achieve
 ![Fig. 2. Three dimensional rendering of CSF spaces enclosed in the mouse skull: Infusion of contrast agent in the lateral ventricles during high-resolution synchrotron radiation-based hard X-ray computed tomography imaging allows 3D visualization with virtual slicing in all directions. Lateral ventricles in blue, third ventricle in green, aqueduct in pink and fourth ventricle in yellow.](images/JP26-invivo-2scan-phase3-postinjection-brain-80-90min_web.png){width="900"}
 
 ### Calibration ramp
-::: {layout-ncol="5"}
+::: {layout-ncol=5}
 ![Fig. 3. *In vitro* calibration scans used for the calibration ramp presented in Experiment 3. Tubes containing different dilutions of CA resulting in a final concentration of 0, 48, 120, 158.4 and 240 mg Ba/mL (left to right)](images/000.png)
 
 ![](images/010.png)
-- 
GitLab